MIT'S PROGRAM ON THE PHARMACEUTICAL INDUSTRY


Annual Report of Research and Educational Programs
1996

Appendix C. Articles and Working Papers

Afuah, Alan. "Public Policy and Pharmaceutical Innovation: A Literature Review and Critique." November 1993.

Afuah, Alan N. "Technical Progress and Product Market Success in Pharmaceuticals: The Case of Cholesterol Ethical Drugs." 1992.

Allen, Thomas J., and Frank Basa. "Managing the Drug Development Process: A Preliminary Report on a Study of Project Management in the Pharmaceutical Industry." January 1994.

Basa, Frank, and Thomas J. Allen. "Project Management and the Locus of Decision-Making in Drug Development." February 1996.

Berndt, Ernst R., Linda T. Bui, David H. Reiley, and Glen L. Urban. "The Economics of a New Industry: The Diffusion of Modern Anti-Ulcer Drugs." January 1994.

Berndt, Ernst R., Linda T. Bui, David H. Reiley, and Glen L. Urban. "The Roles of Marketing, Product Quality, and Price Competition in the Growth and Composition of the U.S. Anti-Ulcer Drug Industry." 1994.

Berndt, Ernst R., Iain Cockburn, and Zvi Griliches. "Pharmaceutical Innovations and Market Dynamics: Tracking Effects on Price Indexes for Anti-Depressant Drugs." Brookings Papers: Microeconomics, 1996.

Berndt, Ernst R., and Stan N. Finkelstein. "Use of Hedonic Methods for Anti-Hypertensive Drugs: Progress Report on a Feasibility Study." 1992.

Berndt, Ernst, Stan N. Finkelstein, Paul E. Greenberg, Alison Keith, Martin B. Keller, and James M. Russell. "Workplace Performance Effects From Chronic Depression and its Treatment." Updated 1997.

Berndt, Ernst R., Stan N. Finkelstein, Paul E. Greenberg, and Laura E. Stiglin. "The Economic Costs of Affective Illness in 1990." Discussion Paper 93-3. Analysis Group, Inc., Cambridge, MA. 1993.

Berndt, Ernst R., Zvi Griliches, and Joshua G. Rosett. "Auditing the Producer Price Index: Micro Evidence from Prescription Pharmaceutical Preparations." Journal of Business & Economic Statistics. 1992.

Chow, Joseph J., and Charles L. Cooney. "The Business of Gene Therapy: Promises and Reality." 1992.

Clarysse, Bart, Koen Debackere, and Peter Temin. "Organizational Ecology in the '90s: A Review and an Assessment." February 1996.

Cockburn, Iain, and Rebecca M. Henderson. "Do Agency Costs Explain Variation in Innovative Performance?" May 1995.

Cockburn, Iain, and Rebecca M. Henderson. "Public-Private Interaction in Pharmaceutical Research." 1995. Forthcoming in National Academy of Sciences.

Cockburn, Iain, and Rebecca M. Henderson. "Racing or Spilling? The Determinants of Research Productivity in the Pharmaceutical Industry." American Enterprise Institute conference volume, 1994.

Cockburn, Iain, and Rebecca M. Henderson. "Racing to Invest: The Dynamics of Competition in Ethical Drug Discovery." Journal of Economics and Business Strategy, Rev. September 1993.

Cockburn, Iain, and Rebecca M. Henderson. "Scale and Scope in Drug Development: Unpacking the Advantages of Size in Pharmaceutical Research." September 1995.

Finkelstein, Stan N., Ernst R. Berndt, and Paul E. Greenberg. "Economics of Depression: A Summary and Review." NDMDA Paper, January 1996.

Finkelstein, Stan N., Ernst R. Berndt, Mark Moore, Paul E. Greenberg, and Alison M. Keith. "The Opportunity Cost of Chronic Illness in the Workplace: Mapping the Landscape." 1997.

Finkelstein, Stan N., Ernst R. Berndt, Paul E. Greenberg, Rod Parsley, James M. Russell, and Martin B. Keller. "Improvement in Subjective Work Performance After Treatment of Chronic Depression: Some Preliminary Results." Psychopharmacology Bulletin 32(1) 33-40, 1996.

Finkelstein, Stan N., and Peter G. Bittinger. "Price Controls and the Competitiveness of Pharmaceutical Firms: A Preliminary Look at the Experience of Five Countries." 1993.

Finkelstein, Stan N., Kevin Neels, and Gregory K. Bell. "Innovation in Cardiac Imaging." In Medical Innovation at the Crossroads, IOM Vol. V, 1995.

Finkelstein, Stan N., Paul E. Greenberg, Ernst R. Berndt, and Jason Verner. "Work Function as a Benchmark of Clinical Response to Antidepressant Medication." January 1997.

Greenberg, Paul E., Laura E. Stiglin, Stan N. Finkelstein, and Ernst R. Berndt. "Depression: A Neglected Major Illness." Journal of Clinical Psychiatry, November 1993.

Greenberg, Paul E., Laura E. Stiglin, Stan N. Finkelstein, and Ernst R. Berndt. "The Economic Burden of Depression." Journal of Clinical Psychiatry, November 1993.

Greenberg, Paul E., Stan N. Finkelstein, and Ernst R. Berndt. "Economic Consequences of Illness in the Workplace." Sloan Management Review, Summer 1995.

Greenberg, Paul E., Ronald C. Kessler, Tara L. Nells, Stan N. Finkelstein, and Ernst R. Berndt. "Depression in the Workplace: A Economic Perspective." In Selective Serotonin Re-uptake Inhibitors (chap. 16). 1996.

Henderson, Rebecca M. "Challenge and Response in the Pharmaceutical Industry." Under the title "Innovation in the Information Age." Harvard Business Review, January 1993.

Henderson, Rebecca M. "The Evolution of Integrative Capability: Innovation in Cardiovascular Drug Discovery." Industrial and Corporate Change, 1994.

Henderson, Rebecca M., and Iain Cockburn. "Measuring Core Competence? Evidence from the Pharmaceutical Industry." Strategic Management Journal, 1993.

Henderson, Rebecca M., and Iain Cockburn. "The Routinization of Radical Innovation: Pharmaceutical Firms and the Biomedical Revolution." July 1995.

Henderson, Rebecca M., and Iain Cockburn. "Scale, Scope and Spillovers: Research Strategy and Research Productivity in the Pharmaceutical Industry." Rand Journal of Economics, 1996.

Keith, Alison, and Ernst R. Berndt. "A Primer on Issues in the Measurement of Price Change and Price Impact: An Application to Pharmaceuticals." September 1994

King, Charles. "Marketing, Product Differentiation, and Competition in the Pharmaceutical Industry." 1996.

Miller, Michael, and Arnold I. Barnett. "Variable Rate Sequential Testing: Another Approach to Clinical Trials?" February 1994.

Munshi, Kaivan D., and Michael R. Reich. "Investment Behavior and Financial Structure: The Case of the Japanese Pharmaceutical Industry." Rand Journal of Economics, December 1993.

Myers, Stewart C., and Christopher Howe. "Life-Cycle Financial Model of Pharmaceutical R&D." August 1996.

Myers, Stewart C., and Lakshmi Shyam-Sunder. "Cost of Capital Estimates for Investment in Pharmaceutical Research and Development." 1992. Forthcoming in Competitive Strategies in the Pharmaceutical Industry.

Neels, Kevin, Stan N. Finkelstein, and Chester Douglass. "Medical Cost Savings from Pentoxifylline Therapy." PharmacoEconomics 5:2, 130-140, February 1994.

Neels, Kevin, Stan N. Finkelstein, Kenneth McKusick, Stephen Carter, and Sandra Black. "Comparative Accuracy of Single Photon Emission Computed Tomography and Planar Stress Thallium Imaging in the Diagnosis of Coronary Artery Disease: A Meta Analysis." 1993.

Raju, G.K., and Charles L. Cooney. "`Benchmarking' Pharmaceutical Manufacturing Performance." 1995.

Scott Morton, Fiona. "Barriers to Entry, Brand Advertising, and Generic Entry in the U.S. Pharmaceutical Industry." January 1994.

Scott Morton, Fiona. "The Strategic Response by Pharmaceutical Firms to the MFN Clause in the Medicaid Rebate Law of 1990." January 1994.

Stern, Scott. "Incentives and Knowledge in Organizational and Technological Change: The Case of Drug Discovery in the 1980s." 1996.

Stern, Scott. "Market Definition and the Returns to Innovation: Substitution Patterns in Pharmaceutical Markets." 1996.

Stern, Scott, and Manuel Trajtenberg. "Calculating the Patient Welfare Benefit from Pharmaceutical Innovation: A Conceptual Framework." March 1997.

Stern, Scott, and Manuel Trajtenberg. "The Empirical Implications of Physician Authority in Pharmaceutical Decisionmaking." March 1997.

Summers, Nevin M. and Charles L. Cooney. "Gene Therapy: Biotech's n+1 Technology." Biotechnology Vol. 11, February 1993.

Temin, Peter, Stan N. Finkelstein, and Bart Clarysse. "Economies of Scale in the Pharmaceutical Industry." February 1996.


Please send comments and suggestions to popi-www@mit.edu

[Back to POPI Home Page]